雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响

张贵明; 倪向敏; 崔涵强; 徐喆; 李硕; 王建

doi:10.16016/j.2097-0927.202204122

您当前的位置：

首页 >

文章列表页 >

雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响

基础医学 | 更新时间：2026-01-09

- 雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响
- Effect of equol intervention on high-fat diet-induced non-alcoholic fatty liver disease in ovariectomized rats
- 陆军军医大学学报 2022年44卷第21期页码：2129-2137
- 作者机构：
  
  400037 重庆，陆军军医大学(第三军医大学)第二附属医院营养科
- 作者简介：
  
  [王建，E-mail: wangjian_1996@aliyun.comWANG Jian, E-mail: wangjian_1996@aliyun.com
- 基金信息：
  
  国家自然基金面上项目(81973040)
- DOI：10.16016/j.2097-0927.202204122
  中图分类号： R285.5;R459.3;R575.5
- 收稿：2022-04-16，
  
  修回：2022-06-17，
  
  纸质出版：2022-11-15
- 稿件说明：
移动端阅览
张贵明, 倪向敏, 崔涵强, 等. 雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响[J]. 陆军军医大学学报, 2022,44(21):2129-2137.

Guiming ZHANG, Xiangmin NI, Hanqiang CUI, et al. Effect of equol intervention on high-fat diet-induced non-alcoholic fatty liver disease in ovariectomized rats[J]. Journal of Army Medical University, 2022, 44(21): 2129-2137.
张贵明, 倪向敏, 崔涵强, 等. 雌马酚干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响[J]. 陆军军医大学学报, 2022,44(21):2129-2137. DOI： 10.16016/j.2097-0927.202204122.

Guiming ZHANG, Xiangmin NI, Hanqiang CUI, et al. Effect of equol intervention on high-fat diet-induced non-alcoholic fatty liver disease in ovariectomized rats[J]. Journal of Army Medical University, 2022, 44(21): 2129-2137. DOI： 10.16016/j.2097-0927.202204122.

摘要

目的

观察雌马酚(equol

Eq)干预对高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝的影响，并探讨其作用机制。

方法

5周龄雌性SD大鼠60只，采用随机数字表法分为6组：假手术组

卵巢切除(ovariectomized

OVX)+高脂饲料(high-fat diet，HFD)喂养组，OVX+HFD+低、中、高剂量[20、40、80 mg/(kg·d)]Eq干预组，OVX+HFD+雌二醇[estradiol，E2，0.25 mg/(kg·d)]干预组。干预12周后

处死大鼠并取材。计算肝指数

检测大鼠血清脂质(TG、TC、HDL-c、LDL-c、FFA)、肝功能(ALT、AST)、炎症因子(TNF-α、IL-6)、雌激素、空腹胰岛素(fasting insulin

FINS)、空腹血糖(fasting plasma glucose

FPG)及肝脏TG、TC、TNF-α、IL-6含量，HE染色观察肝脏组织形态

qRT-PCR检测肝脏TNF-α、IL-6 mRNA表达，Western blot检测肝脏NF-κB p-p65蛋白表达。

结果

与假手术组比较，OVX+HFD组大鼠血清雌激素水平显著下降(

0.05)，出现明显的肝脂肪变性、脂质代谢紊乱、肝功能异常和炎症水平升高；与OVX+HFD组比较，Eq或E2干预后，大鼠血清雌激素、HDL-c水平显著升高，血清TG、TC、HDL-c、LDL-c、FFA、ALT、AST、TNF-α、IL-6水平显著降低(

0.05)，肝组织NF-κB p-p65、TNF-α、IL-6表达水平显著降低(

0.05)，不同程度地改善了肝组织脂肪变性。

结论

Eq干预能有效改善高脂饮食诱导的去卵巢大鼠非酒精性脂肪肝

可能与Eq抑制炎症因子表达有关。

Abstract

Objective

To determine the effect of equol (Eq) intervention on high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in ovariectomized rats and investigate its mechanism of action.

Methods

Sixty 5-week-old female SD rats were randomly divided into 6 groups: sham group

ovariectomized+high-fat diet (OVX +HFD) group

OVX+HFD+low-

medium-

and high-dose Eq groups [20

40 and 80 mg/(kg·d) Eq]

and OVX+ HFD+estradiol group [E2

0.25 mg/(kg·d)]

with 8 rats in each group. After 12 weeks of intervention

the rats were sacrificed and sampled. The liver index was calculated and the serum levels of blood lipid TG

HDL-C

LDL-C

FFA

liver function in indicators ALT

AST

inflammatory factors TNF-α

IL-6

estrogen

fasting insulin (FINS)

fasting plasma glucose (FPG) and liver contents of TG

TNF-α and IL-6 were detected. HE staining was used to observe the morphology of liver tissue. qRT-PCR and Western blotting was employed to detect the mRNA expression of TNF-α and IL-6 and the protein levels of NF-κB p-p65 in the liver tissues

respectively.

Results

Compared with the sham group

the OVX+HFD group had significantly decreased serum estrogen level (

0.05) and obvious hepatic steatosis

dyslipidemia

abnormal liver function and increased levels of inflammatory factors. Eq or E2 intervention resulted in notably increased serum estrogen and HDL-C levels

and remarkably reduced serum TG

HDL-C

LDL-C

FFA

ALT

AST

TNF-α and IL-6 levels (

0.05)

down-regulated expression of NF-κB p-p65

TNF-α and IL-6 in the liver tissues (

0.05)

and certain improvements in steatosis of liver tissues when compared with the OVX+HFD group.

Conclusion

Eq intervention can effectively ameliorate high-fat diet-induced NAFLD in ovariectomized rats

and the mechanism may be partially associated with its inhibition on expression of inflammatory factors.

关键词

Keywords

references

YOUNOSSI Z M. Non-alcoholic fatty liver disease-A global public health perspective[J]. J Hepatol, 2019, 70(3): 531-544. DOI: 10.1016/j.jhep.2018.10.033.

DELLA T S. Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: relevance of estrogen signaling[J]. Front Endocrinol (Lausanne), 2020, 11: 572490. DOI: 10.3389/fendo.2020.572490.

LEE C B, KIM J, JUNG Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J]. Cells, 2019, 8(10): 1259. DOI: 10.3390/cells8101259.

LI H, JIA E N, JIAO J. Phytoestrogens in NAFLD: potential mechanisms of action[J]. Horm Metab Res, 2020, 52(2): 77-84. DOI: 10.1055/a-1089-7710.

PANNEERSELVAM S, PACKIRISAMY R M. Protective effect of soy isoflavones (from Glycine max) on adipose tissue oxidative stress and inflammatory response in an experimental model of post-menopausal obesity: the molecular mechanisms[J]. Biochem Anal Biochem, 2016, 5(2): 1-7. DOI: 10.4172/2161-1009.1000266.

SANKAR P, ZACHARIAH B, VICKNESHWARAN V, et al . Amelioration of oxidative stress and insulin resistance by soy isoflavones (from Glycine max) in ovariectomized Wistar rats fed with high fat diet: the molecular mechanisms[J ] . Exp Gerontol, 2015, 63: 67-75. DOI: 10.1016/j.exger.2015.02.001.

PANNEERSELVAM S, PACKIRISAMY R M, BOBBY Z, et al . Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity)[J ] . J Nutr Biochem, 2016, 38: 57-69. DOI: 10.1016/j.jnutbio.2016.08.007.

ZHANG S M, KUMARI S, GU Y Q, et al . Soy food intake is inversely associated with newly diagnosed nonalcoholic fatty liver disease in the TCLSIH cohort study[J ] . J Nutr, 2020, 150(12): 3280-3287. DOI: 10.1093/jn/nxaa297.

WANG X M, WANG Y, XU W L, et al . Dietary isoflavones intake is i nversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension[J ] . Int J Food Sci Nutr, 2022, 73(1): 60-70. DOI: 10.1080/09637486.2021.1910630.

MAYO B, VÁZQUEZ L, FLÓREZ A B. Equol: a bacterial metabolite from the daidzein isoflavone and its presumed beneficial health effects[J]. Nutrients, 2019, 11(9): 2231. DOI: 10.3390/nu11092231.

SANYAL A J, BRUNT E M, KLEINER D E, et al . Endpoints and clinical trial design for nonalcoholic steatohepatitis[J ] . Hepatology, 2011, 54(1): 344-353. DOI: 10.1002/hep.24376.

BUZZETTI E, PINZANI M, TSOCHATZIS E A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)[J]. Metabolism,2016, 65(8): 1038-1048. DOI: 10.1016/j.metabol.2015.12.012.

HOTAMISLIGIL G S. Inflammation and metabolic disorders[J]. Nature, 2006, 444(7121): 860-867. DOI: 10.1038/nature05485.

CUI J, SHEN Y, LI R N. Estrogen synthesis and signaling pathways during aging: from periphery to brain[J]. Trends Mol Med, 2013, 19(3): 197-209. DOI: 10.1016/j.molmed.2012.12.007.

VENETSANAKI V, POLYZOS S A. Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives[J]. Curr Vasc Pharmacol, 2019, 17(6): 546-555. DOI: 10.2174/1570161116666180711121949.

MANSON J E, CHLEBOWSKI R T, STEFANICK M L, et al . Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials[J ] . JAMA, 2013, 310(13): 1353-1368. DOI: 10.1001/jama.2013.278040.

PRADÈRE J P, HERNANDEZ C, KOPPE C, et al . Negative regulation of NF-κB p65 activity by serine 536 phosphorylation[J ] . Sci Signal, 2016, 9(442): ra85. DOI: 10.1126/scisignal.aab2820.

LIN Z H, CAI F F, LIN N, et al . Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease[J ] . Exp Ther Med, 2014, 7(2): 365-370. DOI: 10.3892/etm.2013.1434.

刘妍, 常丽萍, 高怀林. 胰岛素抵抗的发病机制研究进展[J]. 世界中医药, 2021, 16(11): 1671-1674. DOI: 10.3969/j.issn.1673-7202.2021.11.005.

LIU Y, CHANG L P, GAO H L. Advances in the pathogenesis of insulin resistance[J]. World Chin Med, 2021, 16(11): 1671-1674. DOI: 10.3969/j.issn.1673-7202.2021.11.005.

SANTOLERI D, TITCHENELL P M. Resolving the paradox of hepatic insulin resistance[J]. Cell Mol Gastroenterol Hepatol, 2019, 7(2): 447-456. DOI: 10.1016/j.jcmgh.2018.10.016.

JI G Y, YANG Q H, HAO J, et al . Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms[J ] . Int Immunopharmacol, 2011, 11(6): 762-768. DOI: 10.1016/j.intimp.2011.01.036.

王涛, 梁慧丽. 慢性乙型病毒性肝炎患者中血清HBsAg水平与HBV DNA及肝功能的关系[J]. 河南医学研究, 2019, 28(7): 1303-1304. DOI: 10.3969/j.issn.1004-437X.2019.07.075.

WANG T, LIANG H L. Relationship between serum HBsAg level and HBV DNA and liver function in patients with chronic viral hepatitis B[J]. Henan Med Res, 2019, 28(7): 1303-1304. DOI: 10.3969/j.issn.1004-437X.2019.07.075.

SUBEDI L, JI E, SHIN D, et al . Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates neuroprotection in vitro [J ] . Nutrients, 2017, 9(3): E207. DOI: 10.3390/nu9030207..

LU C, GAO R J, ZHANG Y Y, et al . S-equol, a metabolite of dietary soy isoflavones, alleviates lipopolysaccharide-induced depressive-like behavior in mice by inhibiting neuroinflammation and enhancing synaptic plasticity[J ] . Food Funct, 2021, 12(13): 5770-5778. DOI: 10.1039/d1fo00547b.

BANDARA M, ARUN S J, ALLANSON M, et al . Topical isoflavonoids reduce experimental cutaneous inflammation in mice[J ] . Immunol Cell Biol, 2010, 88(7): 727-733. DOI: 10.1038/icb.2010.26.

RAFⅡ F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol[J]. Metabolites, 2015, 5(1): 56-73. DOI:10.3390/metabo5010056.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

p300在脂代谢紊乱中通过调控SREBP-1c乙酰化促进肝细胞脂质蓄积

估计葡萄糖处理率作为非酒精性脂肪性肝病的便捷识别工具：一项基于NHANES的横断面研究揭示其保护性阈值

LPS诱导小鼠中性粒细胞mGluR5的表达及mGluR5在炎症中的作用

重组人Slit2蛋白预处理可减轻内毒素诱导的大鼠葡萄膜炎

二氢杨梅素抑制高脂喂养小鼠肝脏脂肪蓄积与线粒体融裂基因变化的关系